Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CB1R antagonist 1
Cat. No.:
OB0425LY-175
Appearance:
Solid
Purity:
99.89%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
CB1R antagonist 1 is an agonist to the cannabinoid CB1 receptor with properties that affect the central nervous system and will modulate appetite and pain perception.
Synonyms:
334668-69-8; Cyclohexyl(4-(3-(trifluoromethyl)phenylsulfonyl)piperazin-1-yl)methanone
CAS No.:
334668-69-8
Compound CID:
2729560
Formula:
C18H23F3N2O3S
Formula Weight:
404.45
Specification
Target:
Cannabinoid receptor
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
CB1R antagonist 1 can be used to study the role of the cannabinoid system in weight management, addictive behaviors, and the treatment of neurologically related disorders.
